Antibodies to native types I, 11, TX, and XI collagen were measured, using a 'L51-solid-phase radioimmunoassay, in serum from 104 patients with rheumatic diseases (rheumatoid arthritis, osteoporosis, Paget's disease, or osteoarthritis). In all disease groups, antibodies to type 11 collagen occurred
Antibodies to native type III collagen in the serum of patients with Kawasaki disease
β Scribed by S. Kobayashi; N. Wada; M. Kubo
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 489 KB
- Volume
- 151
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Systemic scleroderma (SSc) is a connective tissue disease characterized by fibrotic, degenerative, and inflammatory changes in the skin and internal organs [4,9]. Cutaneous fibrosis as well as pathological changes in the internal organs may depend on initital perivascular fibrotic processes followed
## Abstract A passive hemagglutination assay was used to detect antibodies to native human collagens and to collagen chains in the sera of 110 rheumatoid patients and those of 75 normal controls. The incidence and titer of anticollagen antibodies in rheumatoid arthritis are high, but in controls th
To assess the clinical value of serum biochemical markers, the aminoterminal peptide of type III procollagen, type IV collagen 7S domain, the central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases, as a marker of hepatic fibrosis, we measured these four serum markers in
To evaluate the diagnostic significance of the collagen Type I11 (Col 1-3) N-terminal propeptide of procollagen Type 111, with respect to activity and degree of liver fibrosis, Col 1-3 serum concentrations were measured in 11 1 patients with chronic liver diseases and in 60 patients were correlated
To evaluate the diagnostic and prognostic significance of the N-terminal propeptide of collagen Type III (Col 1-3) in chronic liver disease, the peptide level was measured in the serum of 4 patients with primary biliary cirrhosis, 5 with chronic persistent hepatitis, 12 with chronic active hepatitis